Membrane-type 1 matrix metalloproteinase: A key enzyme for tumor invasion

Cancer Letters

Volumn 194, Issue 1, 2003, Pages 1-11

  Seiki, Motoharu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cancer; Cell migration; Extracellular matrix; Invasion; Matrix metalloproteinase; Membrane type 1 matrix metalloproteinase; Metastasis; Pericellular proteolysis

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; GELATINASE A; MATRIX METALLOPROTEINASE 14; OLIGOMER; TUMOR MARKER;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CANCER INVASION; CELL INTERACTION; CELL SURFACE; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION;

EID: 0037426578     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00699-7     Document Type: Article

References (100)

1. Nagase H., Woessner J.F. Jr. Matrix metalloproteinases. J. Biol. Chem. 274:1999;21491-21494.
2. Brinckerhoff C.E., Matrisian L. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 3:2002;207-214.
3. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2:2001;163-176.
4. Edwards D.R., Murphy G. Cancer. Proteases - invasion and more. Nature. 394:1998;527-528.
5. Stetler-Stevenson W.G., Yu A.E. Proteases in invasion: matrix metalloproteinases. Semin. Cancer Biol. 11:2001;143-152.
6. Zucker S., Cao J., Chen W.T. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene. 19:2000;6642-6650.
7. Coussens L.M., Fingleton B., Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 295:2002;2387-2392.
8. Bergers G., Javaherian K., Lo K.M., Folkman J., Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 284:1999;808-812.
9. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:1994;61-65.
10. Seiki M. The cell surface: stage for matrix metalloproteinase regulation of migration. Curr. Opin. Cell Biol. 14:2002;624-632.
11. Itoh Y., Kajita M., Kinoh H., Mori H., Okada A., Seiki M. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. J. Biol. Chem. 274:1999;34260-34266.
12. Kojima S., Itoh Y., Matsumoto S., Masuho Y., Seiki M. Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett. 480:2000;142-146.
13. Ellis V., Murphy G. Cellular strategies for proteolytic targeting during migration and invasion. FEBS Lett. 506:2001;1-5.
14. Takino T., Sato H., Yamamoto E., Seiki M. Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain. Gene. 155:1995;293-298.
15. Pei D., Weiss S.J. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271:1996;9135-9140.
16. Sato H., Kinoshita T., Takino T., Nakayama K., Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393:1996;101-104.
17. Yana I., Weiss S.J. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol. Biol. Cell. 11:2000;2387-2401.
18. Cao J., Rehemtulla A., Bahou W., Zucker S. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J. Biol. Chem. 271:1996;30174-30180.
19. Okumura Y., Sato H., Seiki M., Kido H. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator. FEBS Lett. 402:1997;181-184.
20. Rozanov D.V., Ghebrehiwet B., Postnova T.I., Eichinger A., Deryugina E.I., Strongin A.Y. The hemopexin-like C-terminal domain of membrane type-1 matrix metalloproteinase (MT1-MMP) regulates proteolysis of a multifunctional protein gC1qR. J. Biol. Chem. 31:2001;31.
21. Sato T., Kondo T., Fujisawa T., Seiki M., Ito A. Furin-independent pathway of membrane type 1-matrix metalloproteinase activation in rabbit dermal fibroblasts. J. Biol. Chem. 274:1999;37280-37284.
22. Hiraoka N., Allen E., Apel I.J., Gyetko M.R., Weiss S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 95:1998;365-377.
23. Koshikawa N., Giannelli G., Cirulli V., Miyazaki K., Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J. Cell Biol. 148:2000;615-624.
24. Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M., Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272:1997;2446-2451.
25. Imai K., Ohuchi E., Aoki T., Nomura H., Fujii Y., Sato H., Seiki M., Okada Y. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res. 56:1996;2707-2710.
26. Will H., Atkinson S.J., Butler G.S., Smith B., Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J. Biol. Chem. 271:1996;17119-17123.
27. Toth M., Bernardo M.M., Gervasi D.C., Soloway P.D., Wang Z., Bigg H.F., Overall C.M., DeClerck Y.A., Tschesche H., Cher M.L., Brown S., Mobashery S., Fridman R. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. J. Biol. Chem. 275:2000;41415-41423.
28. Takahashi C., Sheng Z., Horan T.P., Kitayama H., Maki M., Hitomi K., Kitaura Y., Takai S., Sasahara R.M., Horimoto A., Ikawa Y., Ratzkin B.J., Arakawa T., Noda M. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc. Natl. Acad. Sci. USA. 95:1998;13221-13226.
29. Oh J., Takahashi R., Kondo S., Mizoguchi A., Adachi E., Sasahara R.M., Nishimura S., Imamura Y., Kitayama H., Alexander D.B., Ide C., Horan T.P., Arakawa T., Yoshida H., Nishikawa S., Itoh Y., Seiki M., Itohara S., Takahashi C., Noda M. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 107:2001;789-800.
30. Nakada M., Yamada A., Takino T., Miyamori H., Takahashi T., Yamashita J., Sato H. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product. N-Tes, Cancer Res. 61:2001;8896-8902.
31. Miyamori H., Takino T., Kobayashi Y., Tokai H., Itoh Y., Seiki M., Sato H. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J. Biol. Chem. 276:2001;28204-28211.
32. Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., Seiki M. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 153:2001;893-904.
33. Deryugina E.I., Bourdon M.A., Jungwirth K., Smith J.W., Strongin A.Y. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int. J. Cancer. 86:2000;15-23.
34. Belkin A.M., Akimov S.S., Zaritskaya L.S., Ratnikov B.I., Deryugina E.I., Strongin A.Y. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J. Biol. Chem. 276:2001;18415-18422.
35. Seiki M. Membrane-type matrix metalloproteinases. Apmis. 107:1999;137-143.
36. Atkinson S.J., Crabbe T., Cowell S., Ward R.V., Butler M.J., Sato H., Seiki M., Reynolds J.J., Murphy G. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J. Biol. Chem. 270:1995;30479-30485.
37. Itoh Y., Takamura A., Ito N., Maru Y., Sato H., Suenaga N., Aoki T., Seiki M. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J. 20:2001;4782-4793.
38. Lehti K., Lohi J., Juntunen M.M., Pei D., Keski-Oja J. Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J. Biol. Chem. 277:2002;8440-8448.
39. Rozanov D.V., Deryugina E.I., Ratnikov B.I., Monosov E.Z., Marchenko G.N., Quigley J.P., Strongin A.Y. Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J. Biol. Chem. 276:2001;25705-25714.
40. Knauper V., Will H., Lopez-Otin C., Smith B., Atkinson S.J., Stanton H., Hembry R.M., Murphy G. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J. Biol. Chem. 271:1996;17124-17131.
41. Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S.A., Mankani M., Robey P.G., Poole A.R., Pidoux I., Ward J.M., Birkedal-Hansen H. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 99:1999;81-92.
42. Zhou Z., Apte S.S., Soininen R., Cao R., Baaklini G.Y., Rauser R.W., Wang J., Cao Y., Tryggvason K. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. USA. 97:2000;4052-4057.
43. Itoh T., Ikeda T., Gomi H., Nakao S., Suzuki T., Itohara S. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 272:1997;22389-22392.
44. Kinoh H., Sato H., Tsunezuka Y., Takino T., Kawashima A., Okada Y., Seiki M. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J. Cell Sci. 109:1996;953-959.
45. Apte S.S., Fukai N., Beier D.R., Olsen B.R. The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis. J. Biol. Chem. 272:1997;25511-25517.
46. Okada A., Tomasetto C., Lutz Y., Bellocq J.P., Rio M.C., Basset P. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J. Cell Biol. 137:1997;67-77.
47. Chan V.T., Zhang D.N., Nagaravapu U., Hultquist K., Romero L.I., Herron G.S. Membrane-type matrix metalloproteinases in human dermal microvascular endothelial cells: expression and morphogenetic correlation. J. Invest. Dermatol. 111:1998;1153-1159.
48. Galvez B.G., Matias-Roman S., Albar J.P., Sanchez-Madrid F., Arroyo A.G. Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J. Biol. Chem. 276:2001;37491-37500.
49. Haas T.L., Davis S.J., Madri J.A. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem. 273:1998;3604-3610.
50. Tokuraku M., Sato H., Murakami S., Okada Y., Watanabe Y., Seiki M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int. J. Cancer. 64:1995;355-359.
51. Polette M., Nawrocki B., Gilles C., Sato H., Seiki M., Tournier J.M., Birembaut P. MT-MMP expression and localisation in human lung and breast cancers. Virchows Arch. 428:1996;29-35.
52. Nawrocki B., Polette M., Marchand V., Monteau M., Gillery P., Tournier J.M., Birembaut P. Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses. Int. J. Cancer. 72:1997;556-564.
53. Nomura H., Sato H., Seiki M., Mai M., Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 55:1995;3263-3266.
54. Mori M., Mimori K., Shiraishi T., Fujie T., Baba K., Kusumoto H., Haraguchi M., Ueo H., Akiyoshi T. Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int. J. Cancer. 74:1997;316-321.
55. Bando E., Yonemura Y., Endou Y., Sasaki T., Taniguchi K., Fujita H., Fushida S., Fujimura T., Nishimura G., Miwa K., Seiki M. Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis. Oncol. Rep. 5:1998;1483-1488.
56. Ohtani H., Motohashi H., Sato H., Seiki M., Nagura H. Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int. J. Cancer. 68:1996;565-570.
57. Imamura T., Ohshio G., Mise M., Harada T., Suwa H., Okada N., Wang Z., Yoshitomi S., Tanaka T., Sato H., Arii S., Seiki M., Imamura M. Expression of membrane-type matrix metalloproteinase-1 in human pancreatic adenocarcinomas. J. Cancer Res. Clin. Oncol. 124:1998;65-72.
58. Ishigaki S., Toi M., Ueno T., Matsumoto H., Muta M., Koike M., Seiki M. Significance of membrane type 1 matrix metalloproteinase expression in breast cancer. Jpn. J. Cancer Res. 90:1999;516-522.
59. Ueno H., Nakamura H., Inoue M., Imai K., Noguchi M., Sato H., Seiki M., Okada Y. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 57:1997;2055-2060.
60. Kanayama H., Yokota K., Kurokawa Y., Murakami Y., Nishitani M., Kagawa S. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer. 82:1998;1359-1366.
61. Yoshizaki T., Sato H., Maruyama Y., Murono S., Furukawa M., Park C.S., Seiki M. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer. 79:1997;139-144.
62. Nakamura H., Ueno H., Yamashita K., Shimada T., Yamamoto E., Noguchi M., Fujimoto N., Sato H., Seiki M., Okada Y. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res. 59:1999;467-473.
63. Afzal S., Lalani E.N., Poulsom R., Stubbs A., Rowlinson G., Sato H., Seiki M., Stamp G.W. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum. Pathol. 29:1998;155-165.
64. Fishman D.A., Bafetti L.M., Stack M.S. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Invasion Metastasis. 16:1996;150-159.
65. Gilles C., Polette M., Piette J., Munaut C., Thompson E.W., Birembaut P., Foidart J.M. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int. J. Cancer. 65:1996;209-213.
66. Yamamoto M., Mohanam S., Sawaya R., Fuller G.N., Seiki M., Sato H., Gokaslan Z.L., Liotta L.A., Nicolson G.L., Rao J.S. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 56:1996;384-392.
67. Nakada M., Nakamura H., Ikeda E., Fujimoto N., Yamashita J., Sato H., Seiki M., Okada Y. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am. J. Pathol. 154:1999;417-428.
68. Forsyth P.A., Wong H., Laing T.D., Rewcastle N.B., Morris D.G., Muzik H., Leco K.J., Johnston R.N., Brasher P.M., Sutherland G., Edwards D.R. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br. J. Cancer. 79:1999;1828-1835.
69. Heppner K.J., Matrisian L.M., Jensen R.A., Rodgers W.H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149:1996;273-282.
70. Takahashi M., Tsunoda T., Seiki M., Nakamura Y., Furukawa Y. Identification of membrane-type matrix metalloproteinase-1 as a target of the b-catenin/Tcf4 complex in human colorectal cancers. Oncogene. 21:2002;5861-5867.
71. Cha H.J., Okada A., Kim K.W., Sato H., Seiki M. Identification of cis-acting promoter elements that support expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) in v-src transformed Madin-Darby canine kidney cells. Clin. Exp. Metastasis. 18:2000;675-681.
72. Stetler-Stevenson W.G., Aznavoorian S., Liotta L.A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9:1993;541-573.
73. Tryggvason K., Hoyhtya M., Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res. Treat. 24:1993;209-218.
74. Sato H., Kida Y., Mai M., Endo Y., Sasaki T., Tanaka J., Seiki M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene. 7:1992;77-83.
75. Okada A., Bellocq J.P., Rouyer N., Chenard M.P., Rio M.C., Chambon P., Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA. 92:1995;2730-2734.
76. Chenard M.P., Lutz Y., Mechine-Neuville A., Stoll I., Bellocq J.P., Rio M.C., Basset P. Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomas. Int. J. Cancer. 82:1999;208-212.
77. Pulyaeva H., Bueno J., Polette M., Birembaut P., Sato H., Seiki M., Thompson E.W. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin. Exp. Metastasis. 15:1997;111-120.
78. Kadono Y., Shibahara K., Namiki M., Watanabe Y., Seiki M., Sato H. Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-darby canine kidney epithelial cells. Biochem. Biophys. Res. Commun. 251:1998;681-687.
79. Hotary K., Allen E., Punturieri A., Yana I., Weiss S.J. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149:2000;1309-1323.
80. Mori H., Tomari T., Koshikawa N., Kajita M., Itoh Y., Sato H., Tojo H., Yana I., Seiki M. CD44 directs membrane-type 1 matrix metalloproteinaseto lamellipodia by associating with its hemopexin-like domain. EMBO J. 21:2002;3949-3959.
81. Zhuge Y., Xu J. Rac1 mediates type I collagen-dependent MMP-2 activation. role in cell invasion across collagen barrier. J. Biol. Chem. 276:2001;16248-16256.
82. Gingras D., Bousquet-Gagnon N., Langlois S., Lachambre M.P., Annabi B., Beliveau R. Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett. 507:2001;231-236.
83. Okamoto I., Kawano Y., Tsuiki H., Sasaki J., Nakao M., Matsumoto M., Suga M., Ando M., Nakajima M., Saya H. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene. 18:1999;1435-1446.
84. Okamoto I., Kawano Y., Matsumoto M., Suga M., Kaibuchi K., Ando M., Saya H. Regulated CD44 cleavage under the control of protein kinase C, calcium influx, and the Rho family of small G proteins. J. Biol. Chem. 274:1999;25525-25534.
85. Okamoto I., Kawano Y., Murakami D., Sasayama T., Araki N., Miki T., Wong A.J., Saya H. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J. Cell Biol. 155:2001;755-762.
86. Webb D.J., Parsons T., Horwitz A.F. Adhesion assembly, disassembly and turnover in migrating cells-over and over and over again. Nat. Cell Biol. 4:2002;97-100.
87. Borland G., Murphy G., Ager A. Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes. J. Biol. Chem. 274:1999;2810-2815.
88. Ratnikov B.I., Rozanov D.V., Postnova T.I., Baciu P.G., Zhang H., DiScipio R.G., Chestukhina G.G., Smith J.W., Deryugina E.I., Strongin A.Y. An alternative processing of integrin alpha v subunit in tumor cells by membrane type-1 matrix metalloproteinase. J. Biol. Chem. 277:2002;7377-7385.
89. Deryugina E.I., Ratnikov B.I., Postnova T.I., Rozanov D.V., Strongin A.Y. Processing of integrin alpha v subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J. Biol. Chem. 277:2002;9749-9756.
90. Giannelli G., Falk-Marzillier J., Schiraldi O., Stetler-Stevenson W.G., Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 277:1997;225-228.
91. Seftor R.E., Seftor E.A., Koshikawa N., Meltzer P.S., Gardner L.M., Bilban M., Stetler-Stevenson W.G., Quaranta V., Hendrix M.J. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res. 61:2001;6322-6327.
92. Stanton H., Gavrilovic J., Atkinson S.J., d'Ortho M.P., Yamada K.M., Zardi L., Murphy G. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J. Cell Sci. 111:1998;2789-2798.
93. Lehti K., Lohi J., Valtanen H., Keski-Oja J. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem. J. 334:1998;345-353.
94. Uekita T., Itoh Y., Yana I., Ohno H., Seiki M. Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J. Cell Biol. 155:2001;1345-1356.
95. Jiang A., Lehti K., Wang X., Weiss S.J., Keski-Oja J., Pei D. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc. Natl. Acad. Sci. USA. 98:2001;13693-13698.
96. Nakahara H., Howard L., Thompson E.W., Sato H., Seiki M., Yeh Y., Chen W.T. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. USA. 94:1997;7959-7964.
97. McCawley L.J., Matrisian L.M. Matrix metalloproteinases: they are not just for matrix anymore! Curr. Opin. Cell Biol. 13:2001;534-540.
98. Cowell S., Knauper V., Stewart M.L., D'Ortho M.P., Stanton H., Hembry R.M., Lopez-Otin C., Reynolds J.J., Murphy G. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem. J. 331:1998;453-458.
99. Lohi J., Lehti K., Valtanen H., Parks W.C., Keski-Oja J. Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene. 242:2000;75-86.
100. Haas T.L., Stitelman D., Davis S.J., Apte S.S., Madri J.A. Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J. Biol. Chem. 274:1999;22679-22685.